High dose sertraline monotherapy fails to protect rhesus macaques from lethal challenge with Ebola virus Makona
Open Access
- 19 July 2017
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 5886
Abstract
The recent epidemic of Ebola virus disease in West Africa resulted in an unprecedented number of cases and deaths. Due to the scope of the outbreak combined with the lack of available approved treatment options, there was strong motivation to investigate any potential drug which had existing data reporting anti-Ebola activity. Drugs with demonstrated antiviral activity in the nonhuman primate models already approved for another indication or for which there was existing safety data were considered to be priorities for evaluation by the World Health Organization. Sertraline hydrochloride was reported to have anti-Ebola activity in vitro alone and in combination with other approved drugs. Although the efficacy was less than 100% in the murine model, the established safety profile of this product, the potential benefit alone and in combination, as well as the lack of other available options prioritized this compound for testing in the Ebola virus intramuscular rhesus macaque challenge model. Using a blinded dosing strategy, we demonstrated that high dose sertraline monotherapy provided no benefit for the prevention of Ebola virus disease in rhesus macaques with regards to reduction of viral load, morbidity, or survival highlighting the challenges of translating results between in vitro and in vivo models.Keywords
This publication has 36 references indexed in Scilit:
- Reduction of influenza virus-induced lung inflammation and mortality in animals treated with a phosophodisestrase-4 inhibitor and a selective serotonin reuptake inhibitorEmerging Microbes & Infections, 2013
- Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regressionJournal of Affective Disorders, 2012
- Ebolavirus Requires Acid Sphingomyelinase Activity and Plasma Membrane Sphingomyelin for InfectionJournal of Virology, 2012
- Ebola virus entry requires the host‐programmed recognition of an intracellular receptorThe EMBO Journal, 2012
- The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-AnalysisNeuropsychopharmacology, 2011
- Selective Serotonin Reuptake Inhibitor Suppression of HIV Infectivity and ReplicationPsychosomatic Medicine, 2010
- Can Animal Models of Disease Reliably Inform Human Studies?PLOS Medicine, 2010
- Avoidable waste in the production and reporting of research evidenceThe Lancet, 2009
- Disease modeling for Ebola and Marburg virusesDisease Models & Mechanisms, 2009
- Why Most Published Research Findings Are FalsePLOS Medicine, 2005